Diaceutics PLC (AIM:DXRX)

United States Steel Statistics

Total Valuation

Diaceutics has a market cap or net worth of GBP 112.86 million. The enterprise value is 101.18 million.

Market Cap	112.86M
Enterprise Value	101.18M

Important Dates

The next estimated earnings date is Wednesday, September 17, 2025.

Earnings Date	Sep 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Diaceutics has 84.54 million shares outstanding. The number of shares has increased by 0.27% in one year.

Current Share Class	84.54M
Shares Outstanding	84.54M
Shares Change (YoY)	+0.27%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	21.85%
Owned by Institutions (%)	50.21%
Float	51.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	109.61
PS Ratio	3.51
PB Ratio	2.83
P/TBV Ratio	4.62
P/FCF Ratio	204.83
P/OCF Ratio	173.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 143.31, with an EV/FCF ratio of 183.63.

EV / Earnings	-59.41
EV / Sales	3.15
EV / EBITDA	143.31
EV / EBIT	n/a
EV / FCF	183.63

Financial Position

The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.03.

Current Ratio	3.80
Quick Ratio	3.66
Debt / Equity	0.03
Debt / EBITDA	1.50
Debt / FCF	1.92
Interest Coverage	-45.46

Financial Efficiency

Return on equity (ROE) is -4.22% and return on invested capital (ROIC) is -3.70%.

Return on Equity (ROE)	-4.22%
Return on Assets (ROA)	-3.23%
Return on Invested Capital (ROIC)	-3.70%
Return on Capital Employed (ROCE)	-6.01%
Revenue Per Employee	161,598
Profits Per Employee	-8,558
Employee Count	199
Asset Turnover	0.68
Inventory Turnover	n/a

Taxes

Income Tax	-205,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.05% in the last 52 weeks. The beta is 0.78, so Diaceutics's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	+2.05%
50-Day Moving Average	124.96
200-Day Moving Average	127.33
Relative Strength Index (RSI)	65.87
Average Volume (20 Days)	233,852

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diaceutics had revenue of GBP 32.16 million and -1.70 million in losses. Loss per share was -0.02.

Revenue	32.16M
Gross Profit	28.27M
Operating Income	-2.46M
Pretax Income	-1.91M
Net Income	-1.70M
EBITDA	552,000
EBIT	-2.46M
Loss Per Share	-0.02

Balance Sheet

The company has 12.74 million in cash and 1.06 million in debt, giving a net cash position of 11.68 million or 0.14 per share.

Cash & Cash Equivalents	12.74M
Total Debt	1.06M
Net Cash	11.68M
Net Cash Per Share	0.14
Equity (Book Value)	39.86M
Book Value Per Share	0.47
Working Capital	21.76M

Cash Flow

In the last 12 months, operating cash flow was 651,000 and capital expenditures -100,000, giving a free cash flow of 551,000.

Operating Cash Flow	651,000
Capital Expenditures	-100,000
Free Cash Flow	551,000
FCF Per Share	0.01

Margins

Gross margin is 87.91%, with operating and profit margins of -7.63% and -5.30%.

Gross Margin	87.91%
Operating Margin	-7.63%
Pretax Margin	-5.93%
Profit Margin	-5.30%
EBITDA Margin	1.72%
EBIT Margin	-7.63%
FCF Margin	1.71%

Dividends & Yields

Diaceutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.27%
Shareholder Yield	n/a
Earnings Yield	-1.51%
FCF Yield	0.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Diaceutics has an Altman Z-Score of 8.9 and a Piotroski F-Score of 4.

Altman Z-Score	8.9
Piotroski F-Score	4